Phacilitate Leaders Forum

17th - 18th SEPTEMBER 2019



Steven  Binninger

Steven Binninger

Cell Therapy Business Lead, ELAMA, Fresenius Kabi

Steven Binninger is the technical and business leader for Fresenius Kabi’s cell and gene therapy automation in Europe, the Middle East, and Asia. Mr. Binninger was responsible for the R&D programs which launched the LOVO Cell Processing System, LOVO DXT Data Management Solution, and the LOVO Medical Device system. He has invented cell and gene therapy process automation technologies with several patents issued globally. He has been published in Cytotherapy and has worked on implementing process automation in upstream and downstream segments for over 30 cell and gene therapy programs globally. Mr. Binninger has a Master’s Degree in Biomedical Engineering from Northwestern University

  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd